Paying users zone. Data is hidden behind: .
Get 1-month access to Boston Scientific Corp. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Boston Scientific Corp. pages available today for free:
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin Quarterly Data
- Analysis of Liquidity Ratios Quarterly Data
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data
- Common Stock Valuation Ratios Quarterly Data
Common-Size Income Statement
Boston Scientific Corp., common-size consolidated income statement
|Income statement item||Description||The company|
|Operating income (loss)||The net result for the period of deducting operating expenses from operating revenues.||Boston Scientific Corp.’s operating income (loss) as a percentage of net sales decreased from 2018 to 2019 and from 2019 to 2020.|
|Income (loss) before income taxes||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Boston Scientific Corp.’s income (loss) before income taxes as a percentage of net sales decreased from 2018 to 2019 and from 2019 to 2020.|
|Net income (loss)||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Boston Scientific Corp.’s net income (loss) as a percentage of net sales increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.|